{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:21:39Z","timestamp":1792603299859,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T00:00:00Z","timestamp":1693094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.annonc.2023.08.010","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T20:48:15Z","timestamp":1693428495000},"page":"1015-1024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial"],"prefix":"10.1016","volume":"34","author":[{"given":"K.","family":"Nilsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Klevebro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Rouvelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lindblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Halldestam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Smedh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Wallner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.K.","family":"Aahlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-O.","family":"Johannessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Alexandersson von D\u00f6beln","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.O.","family":"Hjortland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Quaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bartella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.annonc.2023.08.010_bib1","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.annonc.2022.07.003","article-title":"Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Obermannov\u00e1","year":"2022","journal-title":"Ann Oncol"},{"issue":"suppl 15","key":"10.1016\/j.annonc.2023.08.010_bib2","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1200\/JCO.2021.39.15_suppl.4004","article-title":"Neo-AEGIS (Neoadjuvant trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (modified MAGIC or FLOT protocol) (NCT01726452)","volume":"39","author":"Reynolds","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.annonc.2023.08.010_bib3","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/annonc\/mdw010","article-title":"A\u00a0randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction","volume":"27","author":"Klevebro","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annonc.2023.08.010_bib4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.annonc.2023.08.010_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/1097-0142(196001\/02)13:1<37::AID-CNCR2820130108>3.0.CO;2-6","article-title":"Preoperative irradiation for cancer of the esophagus","volume":"13","author":"Cliffton","year":"1960","journal-title":"Cancer"},{"key":"10.1016\/j.annonc.2023.08.010_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1200\/JCO.2008.17.0506","article-title":"Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction","volume":"27","author":"Stahl","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.annonc.2023.08.010_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(05)70288-6","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial","volume":"6","author":"Burmeister","year":"2005","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.annonc.2023.08.010_bib8","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.annonc.2023.08.010_bib9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/SLA.0000000000000966","article-title":"Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer","volume":"260","author":"Shapiro","year":"2014","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.annonc.2023.08.010_bib10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.athoracsur.2015.09.044","article-title":"Esophagectomy timing after neoadjuvant therapy for distal esophageal adenocarcinoma","volume":"101","author":"Franko","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.annonc.2023.08.010_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijsu.2018.09.013","article-title":"Does timing of esophagectomy following neoadjuvant chemoradiation affect outcomes? A meta-analysis","volume":"59","author":"Qin","year":"2018","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.annonc.2023.08.010_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.21037\/jgo.2017.09.11","article-title":"Complete pathologic response is independent of the timing of esophagectomy following neoadjuvant chemoradiation for esophageal cancer","volume":"9","author":"Singla","year":"2018","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"9","key":"10.1016\/j.annonc.2023.08.010_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox062","article-title":"Appropriate timing for surgery after neoadjuvant chemoradiation for esophageal cancer","volume":"30","author":"Tsang","year":"2017","journal-title":"Dis Esophagus"},{"issue":"1","key":"10.1016\/j.annonc.2023.08.010_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.athoracsur.2014.08.033","article-title":"Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer","volume":"99","author":"Shaikh","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.annonc.2023.08.010_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.athoracsur.2011.05.021","article-title":"Does the timing of esophagectomy after chemoradiation affect outcome?","volume":"93","author":"Kim","year":"2012","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.annonc.2023.08.010_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.21037\/atm.2016.01.28","article-title":"The effect of time interval on esophagectomy after neoadjuvant treatment","volume":"4","author":"Depypere","year":"2016","journal-title":"Ann Transl Med"},{"issue":"3","key":"10.1016\/j.annonc.2023.08.010_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.surg.2018.04.026","article-title":"Timing of esophagectomy after neoadjuvant chemoradiation treatment in squamous cell carcinoma","volume":"164","author":"Franko","year":"2018","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.annonc.2023.08.010_bib18","first-page":"874","article-title":"Timing of esophagectomy in multimodal therapy of esophageal cancer: impact of time interval between neoadjuvant therapy and surgery on outcome and response","volume":"86","author":"Muller","year":"2015","journal-title":"Chirurg"},{"issue":"3","key":"10.1016\/j.annonc.2023.08.010_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ejcts\/ezx132","article-title":"Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing?","volume":"52","author":"Ranney","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"10.1016\/j.annonc.2023.08.010_bib20","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/SLA.0b013e3181fc7f86","article-title":"Interval between neoadjuvant chemoradiotherapy and surgery for squamous cell carcinoma of the thoracic esophagus: does delayed surgery have an impact on outcome?","volume":"252","author":"Ruol","year":"2010","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.annonc.2023.08.010_bib21","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.athoracsur.2013.12.026","article-title":"Does timing of surgical procedure after neoadjuvant chemoradiation affect outcomes in esophageal cancer?","volume":"97","author":"Tessier","year":"2014","journal-title":"Ann Thorac Surg"},{"issue":"13","key":"10.1016\/j.annonc.2023.08.010_bib22","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1245\/s10434-013-3139-7","article-title":"Interval between neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma: does delayed surgery impact outcome?","volume":"20","author":"Chiu","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.annonc.2023.08.010_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2016.2743","article-title":"Association of intervals between neoadjuvant chemoradiation and surgical resection with pathologic complete response and survival in patients with esophageal cancer","volume":"151","author":"Haisley","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.annonc.2023.08.010_bib24","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ejso.2016.03.033","article-title":"Delaying surgery after neoadjuvant chemoradiotherapy does not significantly influence postoperative morbidity or oncological outcome in patients with oesophageal adenocarcinoma","volume":"42","author":"Kathiravetpillai","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.annonc.2023.08.010_bib25","doi-asserted-by":"crossref","first-page":"doz078","DOI":"10.1093\/dote\/doz078","article-title":"Association between time interval from neoadjuvant chemoradiotherapy to surgery and complete histological tumor response in esophageal and gastroesophageal junction cancer: a national cohort study","volume":"33","author":"Klevebro","year":"2020","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.annonc.2023.08.010_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejca.2017.12.009","article-title":"Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: a nationwide study","volume":"91","author":"van der Werf","year":"2018","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.annonc.2023.08.010_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox116","article-title":"Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis","volume":"31","author":"Tie","year":"2018","journal-title":"Dis Esophagus"},{"issue":"5","key":"10.1016\/j.annonc.2023.08.010_bib28","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/SLA.0000000000004340","article-title":"Surgical morbidity and mortality from the multicenter randomized controlled NeoRes II trial: standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for esophageal cancer","volume":"272","author":"Nilsson","year":"2020","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.annonc.2023.08.010_bib29","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/cncr.20916","article-title":"Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation","volume":"103","author":"Chirieac","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.annonc.2023.08.010_bib30","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753423008256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753423008256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T11:07:47Z","timestamp":1731323267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753423008256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0923753423008256"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2023.08.010","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2023.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}]}}